Marksans Pharma has received approval by US Food and Drug Administration (USFDA) for an Abbreviated New Drug Application (ANDA) for Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg.
Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg are therapeutically equivalent to listed drug Zemplar Capsules 1 mcg, 2 mcg and 4 mcg of Abbvie Inc. Paricalcitol is a Synthetic Vitamin D analog. Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in the body. Paricalcitol is used to treat or prevent hyper parathyroidism (overactive para thyroid gland). It has been used to reduce parathyroid hormone level.
Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.
